🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06508008
Recruiting Not applicable

Rapid and Safe Sputum Suction Method Validation

NCT06508008 · tracked via the Priya Life Science China tracker
Sponsor
Affiliated Hospital of Nantong University
Phase
Not applicable
Started
2024-02-18
Last updated
2026-08-05

Condition(s) studied

Sputum

Investigational drug(s) / intervention(s)

continuous negative pressure suctionIntermittent negative pressure sputum suction through oral pharyngeal airway

continuous negative pressure suction: (1) Open the mouth with a tongue depressor; (2) Apply paraffin oil to the front end of the sputum suction tube; (3) Insert a suction tube into the mouth to aspirate phlegm.

Intermittent negative pressure sputum suction through oral pharyngeal airway: (1) Insert the oropharyngeal airway parallel into the oral cavity; (2) Apply paraffin oil to the front end of the sputum suction tube; (3) The suction tube is inserted into the deep oral cavity through the middle lumen of the oropharyngeal airway; (4) Intermittent negative pressure for suction and suction of sputum

Study summary

600 comatose patients admitted to the hospital in China from June 2024 to June 2028 were randomly divided into groups A and B. Group A used intermittent negative pressure suction through oral and pharyngeal ventilation, while group B used continuous negative pressure suction through regular oral and nasal suction.

Eligibility

Sex
ALL
Min age
20 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * 1\. Clinical diagnosis of stroke; 2. Clinical diagnosis of comatose; Exclusion Criteria: * 1\. Clinical diagnosis of multiple organ failure; 2. Clinical diagnosis of multiple organ bleeding;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Affiliated Hospital of Nantong University Nantong Jiangsu Recruiting

More Affiliated Hospital of Nantong University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06508008 on ClinicalTrials.gov ↗ ← All trials in China